|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 951-975 out of 1212. << < 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>
Public Release: 15-Mar-2013
28th Annual EAU CongressNew study: Incidence and mortality of PCa after termination of PSA-based screening Men who participate in biennial PSA based screening have a lower risk of being diagnosed as well as dying from prostate cancer up to 9 years after their last PSA test, according to the results of a new study to be presented at the 28th Annual EAU Congress in Milan. Contact: Ivanka Moerkerken
Public Release: 15-Mar-2013
 Journal of Clinical InvestigationSorting out fertility after childhood cancer In this issue of the Journal of Clinical Investigation, Orwig and colleagues report the development of a multi-parameter sorting approach to separate spermatagonial stem cells from cancerous cells. 
National Institutes of Health, Richard King Mellon Foundation, Magee-Womens Research Institute
Contact: Jillian Hurst
Public Release: 15-Mar-2013
Journal of Clinical InvestigationJCI early table of contents for Mar. 15, 2013 The following release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Mar. 15, 2013, in the JCI: Cytoskeletal dysregulation underlies Buruli ulcer formation; Sorting out fertility after childhood cancer; and many more. Contact: Jillian Hurst
Public Release: 15-Mar-2013
28th Annual EAU CongressJapanese P2 study shows potential of combined vaccine and steroid drug in castration-resistant PCa Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer patients. Contact: Ivanka Moerkerken
Public Release: 15-Mar-2013
28th Annual EAU CongressSurgery is superior to radiotherapy in men with localized PCa, says prize-winning Swedish study Surgery offers better survival benefit for men with localized prostate cancer, according to a large observational study, conducted by a group of researchers in Sweden and the Netherlands. Contact: Ivanka Moerkerken
Public Release: 15-Mar-2013
28th Annual EAU CongressStem cells transplantation technique has high potential as a novel therapeutic strategy for ED Transplantation of mesenchymal stem cells cultivated on the surface of nanofibrous meshes could be a novel therapeutic strategy against post-prostatectomy erectile dysfunction, conclude the authors of a study which is to be presented at the 28th Annual EAU Congress later this week. Contact: Ivanka Moerkerken
Public Release: 15-Mar-2013
28th Annual EAU CongressPCa markers improve predictive performance of existing clinical variables A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China. Contact: Ivanka Moerkerken
Public Release: 15-Mar-2013
28th Annual EAU CongressStudy shows additional role for abiraterone in blocking tumor growth in CRPC As part of an EU-supported IMI-PREDECT consortium, a Dutch study showed that anti-androgenic properties of the drug abiraterone may provide an additional mechanism of action in blocking tumor growth of castration resistant prostate cancer.
IMI-PREDECT Consortium
Contact: Ivanka Moerkerken
Public Release: 14-Mar-2013
PLOS ONENew cancer diagnostic technique debuts Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies. Now a team of Chilean researchers and Carnegie's Wolf Frommer have devised a molecular sensor that can detect levels of lactate in individual cells in real time.
National Institutes of Health, Chilean Government, Carnegie
Contact: Wolf Frommer
Public Release: 14-Mar-2013
Journal of the National Cancer InstituteHigh-fat dairy products linked to poorer breast cancer survival Patients who consume high-fat dairy products following breast cancer diagnosis increase their chances of dying from the disease years later, according to a study by Kaiser Permanente researchers.
NIH/National Cancer Institute
Contact: Vincent Staupe
Public Release: 14-Mar-2013
Journal of Neuro-OphthalmologyBrain stent offers alternative to shunt for fixing potentially blinding vein narrowing A team of interventional neuroradiologists and neurosurgeons at Johns Hopkins reports wide success with a new procedure to treat pseudotumor cerebri, a rare but potentially blinding condition marked by excessive pressure inside the skull, caused by a dangerous narrowing of a vein located at the base of the brain. Contact: David March
Public Release: 14-Mar-2013
BJU InternationalSmoking linked with worse urothelial cancer prognosis in patients, especially women Smoking significantly increases individuals' risk of developing serious forms of urothelial carcinoma and a higher likelihood of dying from the disease, particularly for women. That is the conclusion of a recent study published in BJU International. While the biological mechanisms underlying this gender difference are unknown, the findings indicate that clinicians and society in general should focus on smoking prevention and cessation to safeguard against deadly cancers of the bladder, ureters, and renal pelvis, especially in females. Contact: Amy Molnar
Public Release: 14-Mar-2013
Biomedical Optics ExpressIntense terahertz pulses cause DNA damage but also induce DNA repair Terahertz radiation, a slice of the electromagnetic spectrum that occupies the middle ground between microwaves and infrared light, is rapidly finding important uses in medical diagnostics, security, and scientific research. As scientists and engineers find evermore practical uses for this form of radiation, questions persist about its potential human health risks. Contact: Angela Stark
Public Release: 14-Mar-2013
Human Vaccines & ImmunotherapeuticsHPV vaccine trends point to failures in patient education, vaccine programs Completion rates for the human papillomavirus vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public vaccine financing programs are needed, according to new research from the University of Texas Medical Branch.
NIH/National Institute of Child Health and Human Development
Contact: Lauren Whisenant
Public Release: 14-Mar-2013
Science SignalingStudy shows how vitamin E can help prevent cancer Researchers have identified an elusive anti-cancer property of vitamin E that has long been presumed to exist, but difficult to find.
National Institutes of Health
Contact: Ching-Shih Chen
Public Release: 14-Mar-2013
Public HealthChildren of divorced parents more likely to start smoking Both daughters and sons from divorced families are significantly more likely to initiate smoking in comparison to their peers from intact families, shows a new analysis of 19,000 Americans. Contact: Dominic Ali
Public Release: 13-Mar-2013
Journal of the National Cancer InstituteLower incidence of genital warts in young girls The incidence of genital warts, or condylomata, declined by 93 percent in girls given the HPV vaccine before the age of 14, according to a Swedish national registry study.
Merck, Sharp & Dohme
Contact: Press Office
Public Release: 13-Mar-2013
NatureTapeworm DNA contains drug weak spots Tapeworms cause devastating disease around the world and new treatments are urgently needed. This study describes possible targets on which currently licensed drugs could act, identified by genome sequencing. Re-using existing therapies will help to develop treatments more rapidly. Contact: Aileen Sheehy
Public Release: 13-Mar-2013
Journal of the National Cancer InstituteImplementing HPV vaccinations at a young age is significant for vaccine effectiveness Initial vaccinations for human papillomavirus (HPV) at a young age is important for maximizing quadrivalent HPV vaccine effectiveness according to a Swedish study published March 13 in the Journal of the National Cancer Institute. Contact: Zachary Rathner
Public Release: 13-Mar-2013
Journal of Experimental MedicineBreakthrough in battle against leukemia Scientists at Griffith University's Institute for Glycomics have discovered a critical weakness in leukemic cells, which may pave the way to new treatments. Contact: Helen Wright
Public Release: 13-Mar-2013
Science Translational MedicineNew monoclonal antibody developed that can target proteins inside cancer cells Scientists from Memorial Sloan-Kettering Cancer Center and Eureka Therapeutics have collaborated to create a unique monoclonal antibody that can effectively reach inside a cancer cell.
NIH/National Cancer Institute, Leukemia and Lymphoma Society
Contact: Caitlin Hool
Public Release: 13-Mar-2013
Journal of Biological ChemistryScientists discover novel chemical that controls cell behavior It's the spread of the original cancer tumor that kills most people. That's why cancer researchers vigorously search for drugs that can prevent metastases, the spread of cancer. The research team co-led by Angela Wandinger-Ness, Ph.D., and Larry Sklar, Ph.D., has found a chemical compound that controls cell migration and adhesion, two important characteristics of metastatic cancer cells. The team recently published a paper describing how the first-in-class compound acts on various cells. Contact: Michele Sequeira
Public Release: 13-Mar-2013
JAMA Internal Medicine1 in 4 colonoscopies in Medicare patients found to be potentially inappropriate A new study by researchers at the University of Texas Medical Branch at Galveston published online today in JAMA Internal Medicine shows that one out of four colonoscopies paid for by Medicare is potentially inappropriate under current screening guidelines set forth by the United States Preventive Services Task Force.
National Institutes of Health, Comparative Effectiveness Research on Cancer in Texas, Cancer Prevention Research Institute of Texas
Contact: Molly Dannenmaier
Public Release: 13-Mar-2013
Molecular TherapyEvidence supports blocking immune response to enhance viral therapy against solid tumors Following several years of study, investigators have found more evidence that viral therapy to treat solid tumors can be enhanced by blocking the body's natural immune response.
National Institutes of Health
Contact: Mary Ellen Peacock
Public Release: 13-Mar-2013
Proceedings of the National Academy of SciencesPolo takes the bait A seemingly obscure gene in the female fruit fly that is only active in cells that will become eggs has led researchers at the Stowers Institute for Medical Research to the discovery of a atypical protein that lures, traps, and inactivates the powerful Polo kinase, widely considered the master regulator of cell division. Its human homolog, Polo-like kinase-1, is misregulated in many types of cancer.
Stowers Institute for Medical Research, American Cancer Society
Contact: Gina Kirchweger
Showing releases 951-975 out of 1212. << < 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>
|
Search News Releases
|
|||||||||||||||||||||||||
 |
||||
|
|
 |
|